Dr. Raegan McDonald Mosley, an obstetrician-gynecologist and CEO of Power to Decide, returns to the podcast to talk with Dr. Josh Sharfstein about the Texas case that invalidated FDA approval of the abortion medication mifepristone. They discuss what the ruling might mean in the short term and the broader implications for reproductive health, FDA approval of other drugs, and the field of medicine.
